Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.95 is 33% above its 5-year average of -1.41, near the high end of its 5-year range (-2.35–-0.79).
39.30% above its 12-month average of -1.56.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.32.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:27:33.576Z. Historical observations retain their original dates. Historical series through 2026-05-06.
EARNINGS PER SHARE (EPS)
-0.95
EARNINGS PER SHARE (EPS) AVG TTM
-1.56
EARNINGS PER SHARE (EPS) AVG 3Y
-1.33
EARNINGS PER SHARE (EPS) AVG 5Y
-1.41
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.30%
CURRENT VS 3Y AVG
+28.71%
CURRENT VS 5Y AVG
+32.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
908 Devices Inc.
Market Cap
$508.33M
Earnings Per Share (EPS)
-0.95
TTM Avg
-1.56
3Y Avg
-1.33
5Y Avg
-1.41
Market Cap
$501.13M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.09
3Y Avg
-1.67
5Y Avg
-1.68
Market Cap
$518.16M
Earnings Per Share (EPS)
-7.58
TTM Avg
-39.00
3Y Avg
-56.28
5Y Avg
-76.67
Market Cap
$517.30M
Earnings Per Share (EPS)
-0.78
TTM Avg
-1.17
3Y Avg
-1.45
5Y Avg
-1.68
Market Cap
$495.23M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.81
3Y Avg
-1.01
5Y Avg
-1.63
Market Cap
$495.09M
Earnings Per Share (EPS)
-1.76
TTM Avg
-2.31
3Y Avg
-2.36
5Y Avg
-1.76
Market Cap
$523.60M
Earnings Per Share (EPS)
-2.34
TTM Avg
-1.60
3Y Avg
-1.16
5Y Avg
-0.99
Market Cap
$527.94M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.82
3Y Avg
-0.78
5Y Avg
-1.65
Market Cap
$486.60M
Earnings Per Share (EPS)
0.52
TTM Avg
0.62
3Y Avg
0.43
5Y Avg
-0.09
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 908 Devices Inc. (MASS) | $508.33M | -0.95 | -1.56 | -1.33 | -1.41 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $501.13M | -0.67 | -1.09 | -1.67 | -1.68 |
| Crescent Biopharma, Inc. (CBIO)vs › | $518.16M | -7.58 | -39.00 | -56.28 | -76.67 |
| Altimmune, Inc. (ALT)vs › | $517.30M | -0.78 | -1.17 | -1.45 | -1.68 |
| Evolus, Inc. (EOLS)vs › | $495.23M | -0.52 | -0.81 | -1.01 | -1.63 |
| Oculis Holding AG (OCS)vs › | $495.09M | -1.76 | -2.31 | -2.36 | -1.76 |
| Monopar Therapeutics Inc. (MNPR)vs › | $523.60M | -2.34 | -1.60 | -1.16 | -0.99 |
| Immix Biopharma, Inc. (IMMX)vs › | $527.94M | -0.88 | -0.82 | -0.78 | -1.65 |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 0.52 | 0.62 | 0.43 | -0.09 |
| ProKidney Corp. (PROK)vs › | $532.96M | -0.57 | -0.57 | -0.87 | -0.89 |
Trailing EPS (TTM)
$-0.95
Forward EPS (Est.)
$-0.86
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.01 |
| 2024-12-31 | -2.12 |
| 2023-12-31 | -1.13 |
| 2022-12-31 | -1.07 |
| 2021-12-31 | -0.79 |
| 2020-12-31 | -2.35 |
| 2019-12-31 | -2.02 |
| 2018-12-31 | -0.93 |
